AstraZeneca COVID jab ‘less effective against S Africa variant’

Read MoreBritish drugmaker says its vaccine showed ‘limited efficacy against mild disease’ caused by the South African variant.British drugmaker says its vaccine showed ‘limited efficacy against mild disease’ caused by the South African variant.